SNWV

SANUWAVE Health, Inc. Common Stock

28.20 USD
+0.77
2.81%
At close Mar 12, 4:00 PM EDT
1 day
2.81%
5 days
-3.09%
1 month
2.55%
3 months
2.55%
6 months
2.55%
Year to date
2.55%
1 year
2.55%
5 years
2.55%
10 years
2.55%
 

About: SANUWAVE Health Inc is an ultrasound and shock wave technology company using patented systems of noninvasive, high-energy, acoustic shock waves or low-intensity and non-contact ultrasound for regenerative medicine and other applications. The company's focus is regenerative medicine utilizing noninvasive, acoustic shock waves or ultrasound to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company's two primary systems are UltraMIST and PACE. UltraMIST and PACE are the only two Food and Drug Administration (FDA) approved directed energy systems for wound healing.

Employees: 31

Funds holding %
Analysts bullish %

Fund manager confidence

Research analyst outlook

We haven’t received any recent analyst ratings for SNWV.

Financial journalist opinion

Neutral
GlobeNewsWire
1 week ago
Sanuwave Health to Uplist to the Nasdaq Global Market
Trading Under the Ticker “SNWV” Expected to Begin on March 7, 2025 Trading Under the Ticker “SNWV” Expected to Begin on March 7, 2025
Sanuwave Health to Uplist to the Nasdaq Global Market
Neutral
GlobeNewsWire
3 weeks ago
SANUWAVE Health to Participate in 37th Annual Roth Conference
EDEN PRAIRIE, Minn., Feb. 19, 2025 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound care products, today announced that Morgan Frank, Chief Executive Officer, will participate in the 37th Annual Roth Conference to be held on March 16-18 at the Laguna Cliffs Marriott Resort & Spa in Dana Point, California.
SANUWAVE Health to Participate in 37th Annual Roth Conference
Neutral
GlobeNewsWire
4 months ago
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results
Q3 2024 revenues were $9.4 million, up 89% from Q3 2023. This was an all-time quarterly record for the Company.
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results
Neutral
GlobeNewsWire
4 months ago
SANUWAVE Will Host a Conference Call on November 8, 2024 at 8:30 AM (ET) to Present Q3 Financial Results
EDEN PRAIRIE, Minn., Nov. 04, 2024 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (the "Company" or "SANUWAVE”) (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound care products, will host a live conference call on Friday, November 8, 2024, at 8:30 AM (ET) to present its Q3 2024 financial results.
SANUWAVE Will Host a Conference Call on November 8, 2024 at 8:30 AM (ET) to Present Q3 Financial Results
Neutral
GlobeNewsWire
4 months ago
SANUWAVE Health Announces 1-For-375 Reverse Stock Split
Common Stock Will Begin Trading on a Split-adjusted Basis on October 18, 2024 EDEN PRAIRIE, Minn., Oct. 16, 2024 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (the “Company” or “SANUWAVE”) (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound care products, today announced that, effective at 12:01 a.m.
SANUWAVE Health Announces 1-For-375 Reverse Stock Split
Neutral
Seeking Alpha
6 months ago
SANUWAVE Health Inc. (SNWV) Q2 2024 Earnings Call Transcript
SANUWAVE Health Inc. (OTCQB:SNWV) Q2 2024 Earnings Conference Call August 13, 2024 8:30 AM ET Company Participants Morgan Frank - Chairman and Chief Executive Officer Peter Sorensen - Chief Financial Officer Conference Call Participants Adam Gazzola - Private Investor Operator Good day, everyone, and welcome to SANUWAVE announces highest quarterly revenue in company history Q2 2024 results. At this time, all participants are in a listen-only mode.
SANUWAVE Health Inc. (SNWV) Q2 2024 Earnings Call Transcript
Neutral
GlobeNewsWire
6 months ago
SANUWAVE Announces Record Quarterly Revenues: Q2 FY2024 Financial Results
Q2 2024 revenues were $7.2 million, up 53% from Q2 2023. This was an all-time quarterly record for the Company.
SANUWAVE Announces Record Quarterly Revenues: Q2 FY2024 Financial Results
Neutral
GlobeNewsWire
7 months ago
SANUWAVE Will Host a Conference Call on August 13, 2024 at 8:30 AM (ET) to Present Q2 Financial Results
EDEN PRAIRIE, MN, Aug. 07, 2024 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (the "Company" or "SANUWAVE”) (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound care products, will host a live conference call on Tuesday, August 13, 2024, at 8:30 AM (ET) to present the Q2 2024 financial results.
SANUWAVE Will Host a Conference Call on August 13, 2024 at 8:30 AM (ET) to Present Q2 Financial Results
Neutral
GlobeNewsWire
11 months ago
SANUWAVE Health Announces Preliminary Revenue Results for the First Quarter 2024 (Ended March 31, 2024)
SANUWAVE is pleased to announce preliminary revenues of $5.7 million to $5.9 million for the first quarter ended March 31, 2024. This represents the highest Q1 revenues in company history.
SANUWAVE Health Announces Preliminary Revenue Results for the First Quarter 2024 (Ended March 31, 2024)
Neutral
GlobeNewsWire
11 months ago
SANUWAVE Health Appoints Industry Veteran Peter Sorensen as Chief Financial Officer
Sorensen brings strong finance, forecasting, analysis, and capital markets experience as well as abilities in software, process automation, and human resources to SANUWAVE
SANUWAVE Health Appoints Industry Veteran Peter Sorensen as Chief Financial Officer
Charts implemented using Lightweight Charts™